JP2020500834A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500834A5
JP2020500834A5 JP2019511334A JP2019511334A JP2020500834A5 JP 2020500834 A5 JP2020500834 A5 JP 2020500834A5 JP 2019511334 A JP2019511334 A JP 2019511334A JP 2019511334 A JP2019511334 A JP 2019511334A JP 2020500834 A5 JP2020500834 A5 JP 2020500834A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
cdrh1
cdrl1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019511334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020500834A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2017/050424 external-priority patent/WO2018038684A1/en
Publication of JP2020500834A publication Critical patent/JP2020500834A/ja
Publication of JP2020500834A5 publication Critical patent/JP2020500834A5/ja
Pending legal-status Critical Current

Links

JP2019511334A 2016-08-26 2017-08-28 マクロファージ刺激タンパク質受容体(又はRON(Recepteur d′Origine Nantais))抗体及びその使用 Pending JP2020500834A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
SG10201607147P 2016-08-26
SG10201607147P 2016-08-26
SG10201700393P 2017-01-17
SG10201700393P 2017-01-17
SG10201700521V 2017-01-20
SG10201700521V 2017-01-20
SG10201703234U 2017-04-19
SG10201703234U 2017-04-19
PCT/SG2017/050424 WO2018038684A1 (en) 2016-08-26 2017-08-28 Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2020500834A JP2020500834A (ja) 2020-01-16
JP2020500834A5 true JP2020500834A5 (enExample) 2020-10-08

Family

ID=61246095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019511334A Pending JP2020500834A (ja) 2016-08-26 2017-08-28 マクロファージ刺激タンパク質受容体(又はRON(Recepteur d′Origine Nantais))抗体及びその使用

Country Status (6)

Country Link
US (1) US11225515B2 (enExample)
EP (1) EP3504244A4 (enExample)
JP (1) JP2020500834A (enExample)
CN (1) CN109923129A (enExample)
SG (2) SG10201913858WA (enExample)
WO (1) WO2018038684A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170151281A1 (en) 2015-02-19 2017-06-01 Batu Biologics, Inc. Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
EP3876977A1 (en) 2018-11-06 2021-09-15 The Regents Of The University Of California Chimeric antigen receptors for phagocytosis
US11013764B2 (en) 2019-04-30 2021-05-25 Myeloid Therapeutics, Inc. Engineered phagocytic receptor compositions and methods of use thereof
CN114981409A (zh) 2019-09-03 2022-08-30 美洛德生物医药公司 用于基因组整合的方法和组合物
WO2021066751A1 (en) * 2019-10-02 2021-04-08 Aslan Pharmaceuticals Pte. Ltd. Antigen specific binding domains and antibody molecules
KR20220088438A (ko) * 2019-10-09 2022-06-27 주식회사 에스티큐브앤컴퍼니 글리코실화된 lag3에 대해 특이적인 항체 및 이의 사용 방법
US10980836B1 (en) 2019-12-11 2021-04-20 Myeloid Therapeutics, Inc. Therapeutic cell compositions and methods of manufacturing and use thereof
WO2021202592A2 (en) * 2020-03-30 2021-10-07 Oregon Health & Science University Monoclonal antibodies for intracellular delivery of payloads
EP4240367A4 (en) 2020-11-04 2024-10-16 Myeloid Therapeutics, Inc. MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
CA3212398A1 (en) 2021-03-17 2022-09-22 Daniel Getts Engineered chimeric fusion protein compositions and methods of use thereof
CA3218780A1 (en) 2021-05-11 2022-11-17 Daniel Getts Methods and compositions for genomic integration
CN114317454B (zh) * 2022-03-01 2023-10-03 天津一瑞生物科技股份有限公司 一种鼠抗oxa-48型碳青霉烯酶杂交瘤细胞株,单克隆抗体及应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
DK336987D0 (da) 1987-07-01 1987-07-01 Novo Industri As Immobiliseringsmetode
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8720833D0 (en) 1987-09-04 1987-10-14 Celltech Ltd Recombinant dna product
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
WO1992002551A1 (en) 1990-08-02 1992-02-20 B.R. Centre Limited Methods for the production of proteins with a desired function
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
GB9113120D0 (en) 1991-06-18 1991-08-07 Kodak Ltd Photographic processing apparatus
GB9120467D0 (en) 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
DE4137202A1 (de) 1991-11-12 1993-05-13 Industrieanlagen Betriebsges Korrosionsgeschuetzte laengenverstellung
FR2716640B1 (fr) 1994-02-28 1996-05-03 Procedes Machines Speciales Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion.
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
GB9812545D0 (en) 1998-06-10 1998-08-05 Celltech Therapeutics Ltd Biological products
US6908963B2 (en) 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
JP4603894B2 (ja) 2002-12-03 2010-12-22 ユセベ ファルマ ソシエテ アノニム 抗体産生細胞を同定するためのアッセイ
CN100543135C (zh) * 2003-02-28 2009-09-23 田边三菱制药株式会社 单克隆抗体及编码其的基因、药物组合物和诊断试剂
GB0312481D0 (en) 2003-05-30 2003-07-09 Celltech R&D Ltd Antibodies
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
AU2004253738A1 (en) 2003-07-01 2005-01-13 Ucb Pharma S.A. Modified antibody Fab fragments
KR101028952B1 (ko) 2003-08-14 2011-04-12 어레이 바이오파마 인크. 수용체 티로신 키나아제 억제제로서의 퀴나졸린 유사체
GB0411186D0 (en) 2004-05-19 2004-06-23 Celltech R&D Ltd Biological products
GB0412181D0 (en) 2004-06-01 2004-06-30 Celltech R&D Ltd Biological products
GB0619291D0 (en) 2006-09-29 2006-11-08 Ucb Sa Altered antibodies
UY31478A1 (es) 2007-11-21 2009-07-17 Inhibicion del receptor para la proteina estimulante del macrofago (ron) y métodos para el tratamiento de lo mismo
BRPI0920707A2 (pt) 2008-10-02 2015-12-29 Respivert Ltd compostos
TWI480050B (zh) 2009-02-10 2015-04-11 Daiichi Sankyo Co Ltd 抗-mst1r抗體及其用途
SG181952A1 (en) * 2009-12-29 2012-07-30 Emergent Product Dev Seattle Heterodimer binding proteins and uses thereof
WO2012006341A2 (en) 2010-07-06 2012-01-12 Aveo Pharmaceuticals, Inc. Anti-ron antibodies
UY33492A (es) * 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
CA2848410A1 (en) 2011-09-16 2013-03-21 The Trustees Of The University Of Pennsylvania Rna engineered t cells for the treatment of cancer
EP3083695A4 (en) 2013-12-16 2017-11-15 Texas Tech University System Anti-ron monoclonal antibodies as a cytotoxic drug delivery system for targeted cancer therapy

Similar Documents

Publication Publication Date Title
JP2020500834A5 (enExample)
JP2019532056A5 (enExample)
JP2022093564A5 (enExample)
JP2022101693A5 (enExample)
JP2024167313A5 (enExample)
JP2018505177A5 (enExample)
JP2020502271A5 (enExample)
JP2020509027A5 (enExample)
FI3484915T3 (fi) Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä
JP2010535713A5 (enExample)
JP2018527919A5 (enExample)
JP2017529838A5 (enExample)
JP2017533694A5 (enExample)
JP2016538318A5 (enExample)
JP2015534579A5 (enExample)
JP2015503909A5 (enExample)
JP2010520290A5 (enExample)
JP2020522280A5 (enExample)
JP2017521054A5 (enExample)
JP2013508292A5 (enExample)
JP2024016024A5 (enExample)
JPWO2023026791A5 (enExample)
JP2020533965A5 (enExample)
JP2018528759A5 (enExample)
JPWO2020014132A5 (enExample)